Clinicopathologic and molecular characteristics of EGFR-mutant lung adenocarcinomas that transform to small cell lung cancer after TKI therapy

BACKGROUND: Small cell lung cancer (SCLC) transformation is one of the mechanisms of drug resistance to tyrosine kinase inhibitors (TKIs) in advanced epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) and represents an increasingly recognized clinical dilemma. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Li, Bazhenova, Lyudmila, Gold, Kathryn, Tran, Lisa, Hilburn, Van, Vu, Peter, Patel, Sandip Pravin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988081/
https://www.ncbi.nlm.nih.gov/pubmed/35399568
http://dx.doi.org/10.21037/tlcr-21-665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988081/
https://www.ncbi.nlm.nih.gov/pubmed/35399568
http://dx.doi.org/10.21037/tlcr-21-665

Ejemplares similares